Breviscapine regulates lipid metabolism of microglia via the ADORA1/PPARα/ACOX1 pathway to promote spinal cord injury recovery
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115145 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Fan Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hosptial, Quzhou, Zhejiang 324000, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Microglia, Lipid Metabolism, Receptor, Adenosine A1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a disabling disorder with limited therapeutic approaches currently available. The activation of microglia and the consequent dysregulation of lipid metabolism play a crucial role in the pathological process of SCI. Breviscapine (Bre), as a traditional Chinese medicinal extract, has demonstrated potential regulatory effects on lipid metabolism; however, the specific mechanism underlying its role in SCI recovery remains undefined. This study aims to investigate the mechanism through which Bre regulates microglial lipid metabolism via the adenosine A1 receptor (ADORA1)/peroxisome proliferator-activated receptor α (PPARα)/acyl-CoA oxidase 1 (ACOX1) pathway, thereby facilitating SCI recovery. Through the establishment of a mouse model of SCI, we discovered that Bre treatment could significantly improve lipid metabolism in the injured spinal cord area, modulate the inflammatory microenvironment of the spinal cord, and promote the recovery of motor functions in mice. Mechanistic studies revealed that Bre upregulated the expression of ADORA1, which subsequently activated PPARα and its downstream target ACOX1, enhancing lipid metabolism in microglia. This metabolic shift reduced lipid accumulation and inflammatory responses, thereby promoting the formation of a neuroprotective microenvironment. Our research findings Bre in promoting SCI recovery and emphasize the significance of the ADORA1/PPARα/ACOX1 pathway as a potential therapeutic target for SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hosptial, Quzhou, Zhejiang 324000, China.
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hosptial, Quzhou, Zhejiang 324000, China. Electronic address: whan0115@wmu.edu.cn.
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hosptial, Quzhou, Zhejiang 324000, China. Electronic address: zwj041519@wmu.edu.cn.
Zitieren
APA
Shi, F., Wang, S., Wu, C., Wen, H., & Zhou, W. (2025). Breviscapine regulates lipid metabolism of microglia via the ADORA1/PPARα/ACOX1 pathway to promote spinal cord injury recovery. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115145
Vancouver
Shi F, Wang S, Wu C, Wen H, Zhou W. Breviscapine regulates lipid metabolism of microglia via the ADORA1/PPARα/ACOX1 pathway to promote spinal cord injury recovery. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115145
BibTeX
@article{Shi2025,
author = {Shi, Fan and Wang, Siqi and Wu, Congwei and Wen, Han and Zhou, Weijun},
title = {Breviscapine regulates lipid metabolism of microglia via the ADORA1/PPARα/ACOX1 pathway to promote spinal cord injury recovery},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115145}
}
EUVIMED